Paper
Document
Submit new version
Download
Flag content
0

SAT-198 ASC41, a selective THRβ agonist significantly reduces liver fat and ALT in biopsy-confirmed MASH patients after 12-week treatment: an interim analysis of a 52-week serial liver biopsy study

0
TipTip
Save
Document
Submit new version
Download
Flag content


Best
Best
Newest
Upvoted
Start the discussion.
This paper has not yet been discussed.